ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,397,755 | -23.5% | 439,955 | -5.8% | 0.07% | -15.3% |
Q2 2023 | $3,135,489 | -24.0% | 467,286 | -0.0% | 0.08% | -28.6% |
Q1 2023 | $4,127,098 | +201714.1% | 467,395 | +74.6% | 0.12% | +85.9% |
Q4 2022 | $2,045 | -99.9% | 267,631 | -4.0% | 0.06% | 0.0% |
Q3 2022 | $1,985,000 | -16.5% | 278,731 | -5.2% | 0.06% | -11.1% |
Q2 2022 | $2,378,000 | -46.2% | 293,953 | -7.6% | 0.07% | -31.4% |
Q1 2022 | $4,416,000 | -53.6% | 318,145 | -6.3% | 0.10% | -45.0% |
Q4 2021 | $9,525,000 | +1.0% | 339,461 | +22.4% | 0.19% | -2.1% |
Q3 2021 | $9,427,000 | -28.3% | 277,343 | -13.8% | 0.20% | -17.4% |
Q2 2021 | $13,154,000 | +14.9% | 321,921 | +13.2% | 0.24% | +11.3% |
Q1 2021 | $11,446,000 | -34.8% | 284,293 | -4.2% | 0.21% | -36.5% |
Q4 2020 | $17,550,000 | +10.3% | 296,806 | -9.3% | 0.33% | -20.9% |
Q3 2020 | $15,913,000 | -11.8% | 327,230 | -12.3% | 0.42% | -17.7% |
Q2 2020 | $18,048,000 | +68.5% | 373,047 | -3.3% | 0.51% | +33.6% |
Q1 2020 | $10,712,000 | +21.1% | 385,590 | +30.5% | 0.38% | +70.7% |
Q4 2019 | $8,843,000 | – | 295,549 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |